← Back to Patent Explorer
US4244943A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for preparing urokinase injection

Assignee: Sumitomo Chemical Co Ltd
•
Filing: 1979-05-09
•
Granted: 1981-01-13
•
Expires: 1999-05-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for preparing a stable urokinase injection by the liophilization of urokinase which comprises liophilizing an aqueous solution containing urokinase, human serum albumin and one or more amino acid compounds selected from polar amino acids and salt thereof. The urokinase injection obtained according to this method is excellent in the storing stability as compared with conventional urokinase preparations for injection.

Inventors

  • 👤 Yoshiya Yamahira
  • 👤 Keiji Fujioka
  • 👤 Yoshiko Okuzawa
  • 👤 Seiko Miura
  • 👤 Shigeji Sato

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 11:42
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6456; C12N9/6462; A; A61; A61K; A61K47/00; A61K47/06; A61K47/16; A61K47/18; A61K47/183; A61K47/30; A61K47/42; A61K9/00; A61K9/0012; A61K9/0019; C12N9/96; C12Y; C12Y304/00; C12Y304/21; C12Y304/21073

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 72 words
A method for preparing a stable urokinase composition suitable for injection into the human body by the lyophilization of urokinase which comprises lyophilizing an aqueous solution containing urokinase, human serum albumin and one or more amino acid compounds selected from the group consisting of glutamic acid, threonine, histidine, serine, glutamine, aspartic acid, arginine and salts thereof, said amino acid compound and human serum albumin being present in amounts effective to stabilize urokinase.
Claim 2
Independent Claim 72 words
A method for preparing a stable urokinase composition suitable for injection into the human body by the lyophilization of urokinase which comprises lyophilizing an aqueous solution containing urokinase, human serum albumin and one or more amino acid compounds selected from the group consisting of glutamic acid, threonine, histidine, serine, glutamine, aspartic acid, arginine and salts thereof, said amino acid compound and human serum albumin being present in amounts effective to stabilize urokinase.
Claim 3
Dependent Claim 22 words
A method according to claim 1, wherein the amino acid compound is glutamic acid or sodium salt thereof, threonine, arginine or histidine.
Claim 4
Independent Claim 49 words
A method for preparing a stable urokinase composition suitable for injection into the human body by the lyophilization of urokinase which comprises lyophilizing an aqueous solution containing urokinase, human serum albumin and glutamic acid, said glutamic acid and human serum albumin being present in amounts effective to stabilize urokinase.
Claim 5
Independent Claim 49 words
A method for preparing a stable urokinase composition suitable for injection into the human body by the lyophilization of urokinase which comprises lyophilizing an aqueous solution containing urokinase, human serum albumin and glutamic acid, said glutamic acid and human serum albumin being present in amounts effective to stabilize urokinase.
Claim 6
Dependent Claim 43 words
A method according to claim 1, wherein the ratio of a mixture of human serum albumin and the amino acid compound to urokinase is 10-50 mg of the sum of human serum albumin and the amino acid compound to 6,000-60,000 IU of urokinase.
Claim 7
Dependent Claim 23 words
A method according to claim 4, wherein the weight ratio of human serum albumin to the amino acid compound is 1:0.05 to 1:10.
Claim 8
Dependent Claim 14 words
A method according to claim 5, wherein the weight ratio is 1:0.1 to 1:4.
Claim 9
Dependent Claim 50 words
A lyophilized urokinase composition comprising urokinase, human serum albumin, and one or more amino acid compounds selected from the group consisting of glutamic acid, threonine, histidine, serine, glutamine, aspartic acid, arginine and salts thereof, said amino acid compound and human serum albumin being present in amounts effective to stabilize urokinase.
Claim 10
Dependent Claim 50 words
A lyophilized urokinase composition comprising urokinase, human serum albumin, and one or more amino acid compounds selected from the group consisting of glutamic acid, threonine, histidine, serine, glutamine, aspartic acid, arginine and salts thereof, said amino acid compound and human serum albumin being present in amounts effective to stabilize urokinase.
Claim 11
Dependent Claim 34 words
A lyophilized urokinase composition according to claim 7, wherein the amino acid compound is glutamic acid or sodium salt thereof, threonine, arginine hydrochloric acid salt of arginine, histidine or hydrochloric acid salt of histidine.
Claim 12
Dependent Claim 27 words
A lyophilized urokinase composition comprising urokinase, human serum albumin and glutamic acid, said glutamic acid and human serum albumin being present in amounts effective to stabilize urokinase.
Claim 13
Dependent Claim 27 words
A lyophilized urokinase composition comprising urokinase, human serum albumin and glutamic acid, said glutamic acid and human serum albumin being present in amounts effective to stabilize urokinase.
Claim 14
Dependent Claim 43 words
A lyophilized urokinase composition according to claim 7, wherein the ratio of human serum albumin and the amino acid compound to urokinase is 10-50 mg of the sum of human serum albumin and the amino acid compound to b 6,000-60,000 IU of urokinase.
Claim 15
Dependent Claim 25 words
A lyophilized urokinase composition according to claim 7, wherein the weight ratio of human serum albumin to the amino acid compound is 1:0.05 to 1:10.
Claim 16
Dependent Claim 16 words
A lyophilized urokinase composition according to claim 11, wherein the weight ratio is 1:0.1 to 1:4.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-01-13 1984-07-14 1985-01-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-01-13 1988-07-14 1989-01-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-01-13 1992-07-14 1993-01-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag